These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 34695076)

  • 21. A qualitative study to explore health professionals' experience of treating gout: understanding perceived barriers to effective gout management.
    Humphrey C; Hulme R; Dalbeth N; Gow P; Arroll B; Lindsay K
    J Prim Health Care; 2016 Jun; 8(2):149-56. PubMed ID: 27477557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population.
    Robinson PC; Taylor WJ; Dalbeth N
    J Rheumatol; 2015 Sep; 42(9):1702-7. PubMed ID: 26233513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Living with gout in New Zealand: an exploratory study into people's knowledge about the disease and its treatment.
    Martini N; Bryant L; Te Karu L; Aho L; Chan R; Miao J; Naidoo C; Singh H; Tieu A
    J Clin Rheumatol; 2012 Apr; 18(3):125-9. PubMed ID: 22426580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient awareness, knowledge and use of colchicine: an exploratory qualitative study in the Counties Manukau region, Auckland, New Zealand.
    Rebello C; Thomson M; Bassett-Clarke D; Martini N
    J Prim Health Care; 2016 Jun; 8(2):140-8. PubMed ID: 27477556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial genetic variation and gout in Māori and Pacific people living in Aotearoa New Zealand.
    Gosling AL; Boocock J; Dalbeth N; Harré Hindmarsh J; Stamp LK; Stahl EA; Choi HK; Matisoo-Smith EA; Merriman TR
    Ann Rheum Dis; 2018 Apr; 77(4):571-578. PubMed ID: 29247128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gout in women: differences in risk factors in young and older women.
    Kumar S; Gupta R; Suppiah R
    N Z Med J; 2012 Oct; 125(1363):39-45. PubMed ID: 23159900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pounamu: Achieving health equity in Aotearoa New Zealand: the contribution of medicines optimisation.
    Te Karu L; Bryant L; Harwood M; Arroll B
    J Prim Health Care; 2018 Mar; 10(1):11-15. PubMed ID: 30068445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of gout clinic in a tertiary hospital setting.
    Leonardo N; Lester S; Whittle S; Rischmueller M
    Intern Med J; 2020 Jan; 50(1):117-120. PubMed ID: 31943621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inpatient management of gout in a New Zealand hospital: a retrospective audit.
    Kennedy NJ; Healy PJ; Harrison AA
    Int J Rheum Dis; 2016 Feb; 19(2):205-10. PubMed ID: 25873399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gout in Aotearoa New Zealand: the equity crisis continues in plain sight.
    Dalbeth N; Dowell T; Gerard C; Gow P; Jackson G; Shuker C; Te Karu L
    N Z Med J; 2018 Nov; 131(1485):8-12. PubMed ID: 30408813
    [No Abstract]   [Full Text] [Related]  

  • 31. Pathways to ambulatory sensitive hospitalisations for Māori in the Auckland and Waitemata regions.
    Barker C; Crengle S; Bramley D; Bartholomew K; Bolton P; Walsh M; Wignall J
    N Z Med J; 2016 Oct; 129(1444):15-34. PubMed ID: 27806026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Access to general practice for Pacific peoples: a place for cultural competency.
    Ludeke M; Puni R; Cook L; Pasene M; Abel G; Sopoaga F
    J Prim Health Care; 2012 Jun; 4(2):123-30. PubMed ID: 22675696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inequity in dialysis related practices and outcomes in Aotearoa/New Zealand: a Kaupapa Māori analysis.
    Huria T; Palmer S; Beckert L; Williman J; Pitama S
    Int J Equity Health; 2018 Feb; 17(1):27. PubMed ID: 29458366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergency COVID-19 funding to general practices in early 2020: lessons for future allocation to support equity.
    Selak V; Crengle S; Harwood M; Murton S; Crampton P
    N Z Med J; 2021 Jul; 134(1538):102-110. PubMed ID: 34239149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-reported gout attack frequency and allopurinol use in general practice in the Netherlands: a prospective observational cohort study protocol.
    van Leeuwen KDB; Bohnen AM; Jacobs ML; van Der Lei J; Janssens HJEM; Koffeman AR; Bindels PJE; Bierma-Zeinstra SMA
    BMJ Open; 2018 Nov; 8(11):e024335. PubMed ID: 30478125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphoribosyltransferase levels of Maori subjects with gout.
    Palmer HL; Fujimoto WY; Palmer DG; Seegmiller JE
    N Z Med J; 1969 Dec; 70(451):403-5. PubMed ID: 17243311
    [No Abstract]   [Full Text] [Related]  

  • 37. Cost-effectiveness of sequential urate lowering therapies for the management of gout in Singapore.
    Pruis SL; Jeon YK; Pearce F; Thong BY; Aziz MIA
    J Med Econ; 2020 Aug; 23(8):838-847. PubMed ID: 32301360
    [No Abstract]   [Full Text] [Related]  

  • 38. Medication risk management and health equity in New Zealand general practice: a retrospective cross-sectional study.
    Leitch S; Zeng J; Smith A; Stokes T
    Int J Equity Health; 2021 May; 20(1):119. PubMed ID: 33975606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The challenges of managing gout in primary care: Results of a best-practice audit.
    Stamp LK; Chapman P; Hudson B; Frampton C; Hamilton G; Judd A
    Aust J Gen Pract; 2019 Sep; 48(9):631-637. PubMed ID: 31476837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD).
    Mikuls TR; Farrar JT; Bilker WB; Fernandes S; Saag KG
    Rheumatology (Oxford); 2005 Aug; 44(8):1038-42. PubMed ID: 15870145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.